Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00262899 · ClinicalTrials.gov registry record · Phase 3
Genetic Counseling or Usual Care in Helping Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I, Stage II, or Stage IIIA Breast Cancer Make Treatment Decisions
A Phase 3 study, sponsored by Georgetown University.
- Completed
- Registry status
- Phase 3
- Development phase
- 331
- Enrollment target
NCT00262899 is a Phase 3 study that has completed, run by Georgetown University. The registered enrollment target is 331 participants.
The verdict
NCT00262899, a Phase 3 study, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 331 participants
- Enrollment target
Study Summary
RATIONALE: Genetics education and counseling may help patients make treatment decisions. It is not yet known how genetic counseling or usual care influence patient treatment decisions for breast cancer. PURPOSE: This randomized clinical trial is studying how well genetic counseling works compared to usual care in helping patients with newly diagnosed ductal carcinoma in situ, stage I, stage II, or stage IIIA breast cancer make treatment decisions.
Interventions
- OTHER educational intervention
- PROCEDURE psychosocial assessment and care
- BEHAVIORAL counseling intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 331 participants |
| Start Date | 2005-08 |
| Est. Completion | 2011-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00262899
The ClinicalTrials.gov registry entry for NCT00262899 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 331 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which educational intervention is the first listed.
NCT00262899 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00262899 about?
NCT00262899 is a clinical study titled "Genetic Counseling or Usual Care in Helping Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I, Stage II, or Stage IIIA Breast Cancer Make Treatment Decisions". RATIONALE: Genetics education and counseling may help patients make treatment decisions. It is not yet known how genetic counseling or usual care influence patient treatment decisions for breast cancer. PURPOSE: This randomized clinical trial is studying how well genetic counseling works compared t...
What is the current status of trial NCT00262899?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 331 participants. The study started on 2005-08. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00262899?
The interventions under investigation include: educational intervention (OTHER), psychosocial assessment and care (PROCEDURE), counseling intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00262899?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.